Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


BLOOD IMMUNOGLOBULIN G INCREASED side effect

What is BLOOD IMMUNOGLOBULIN G INCREASED ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   BLOOD IMMUNOGLOBULIN G INCREASED and Recently Reported Side Effects   BLOOD IMMUNOGLOBULIN G INCREASED and 15 most Active Side Effect polls   BLOOD IMMUNOGLOBULIN G INCREASED and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with BLOOD IMMUNOGLOBULIN G INCREASED

ARANESP  CLARITHROMYCIN  DARBEPOETIN  DECADRON  EXJADE  FABRAZYME  FURADANTIN  IDURSULFASE  LAMISIL  LEVAQUIN  LIPITOR  MENOTROPHIN  MYCOPHENOLATE  MYOZYME  PROGRAF  REVLIMID  ROSIGLITAZONE  STRATTERA  TAHOR  TEMODAL  TERBINAFINE  THALOMID  THALOMIDE  VELCADE  ZETIA  ZITHROMAX  


Revlimid Side Effects Report #5646236-3
Physician from UNITED STATES reported REVLIMID problem on Dec 07, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient recovered.

Velcade Side Effects Report #5578041-0
VELCADE problem was reported by a Physician from JAPAN on Dec 12, 2007. Male patient, 56 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, bronchopulmonary aspergillosis, platelet count decreased, pulmonary alveolar haemorrhage, sepsis, . VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, DEXAMETHASONE, FAMOTIDINE, OMEPRAL, FLAVITAN, ALLOPURINOL, MAGNESIUM OXIDE, BAKTAR. Patient died on 06/12/2007.

Mycophenolate Side Effects Report #5512744-9
Physician from ARGENTINA reported MYCOPHENOLATE MOFETIL problem on Oct 31, 2007. Female patient, 16 years of age, weighting 132.3 lb, was diagnosed with lupus nephritis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, blood immunoglobulin m increased, cardiomegaly, hypertension, infection, lupus nephritis, lymphadenopathy, odynophagia, oliguria, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE, FUROSEMIDE. Patient was hospitalized and became disabled. Patient recovered.

Thalomid Side Effects Report #5498415-6
THALOMID problem was reported by a Physician from UNITED STATES on Oct 18, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, blood urea increased, disease progression, fall, haematocrit decreased, haemoglobin decreased, limb injury, loss of consciousness, multiple myeloma, . THALOMID dosage: 100 MG, QD, ORAL. During the same period patient was treated with COZAAR, LIPITOR, NEXIUM, COLACE, B ELX, MAGNESIUM, COUMADIN, SELENIUM. Patient recovered.


Tahor Side Effects Report #5449455-4
Consumer or non-health professional from FRANCE reported TAHOR problem on Sept 03, 2007. Female patient, 65 years of age, was treated with TAHOR. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, myalgia, . TAHOR dosage: unknown. Patient recovered.

Thalomide Side Effects Report #5405698-7
THALOMIDE problem was reported by a Physician from UNITED STATES on July 24, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma and was treated with THALOMIDE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, blood urea increased, fall, haematocrit decreased, haemoglobin decreased, no therapeutic response, platelet count decreased, red blood cell count decreased, skeletal injury, . THALOMIDE dosage: 100 MG, QD, ORAL. During the same period patient was treated with COZAAR, LIPITOR, NEXIUM, COLACE, MAGNESIUM, COUMADIN, SELENIUM. Patient recovered.

Idursulfase Side Effects Report #5406182-7
Physician from UNITED STATES reported IDURSULFASE problem on July 18, 2007. Male patient, child 8 years of age, weighting 50.04 lb, was diagnosed with mucopolysaccharidosis ii and was treated with IDURSULFASE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, blood potassium decreased, blood sodium decreased, decreased appetite, diarrhoea, dysgeusia, fatigue, iron deficiency anaemia, pharyngitis streptococcal, . IDURSULFASE dosage: (11.5 MG, 1 IN 1 WK), INTRAVENOUS DRIP. During the same period patient was treated with NASONEX, SINGULAIR. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5797673-8
REVLIMID problem was reported by a Physician from UNITED STATES on June 24, 2008. Male patient, 83 years of age, weighting 135.0 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, disease progression, . REVLIMID dosage: 25 MG, ORAL. During the same period patient was treated with KEFLEX, DECADRON, LASIX, MIRALAX, TOPROL, POTASSIUM, ALTACE, SENOKOT. Patient died on 12/06/2007.

Zithromax Side Effects Report #5363254-3
Physician from UNITED STATES reported ZITHROMAX problem on June 18, 2007. Female patient, 77 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, bronchial wall thickening, cardiomegaly, hepatitis chronic active, hilar lymphadenopathy, hypergammaglobulinaemia, inflammation, interstitial lung disease, liver injury, . ZITHROMAX dosage: unknown. During the same period patient was treated with MACROBID, SYNTHROID, PRILOSEC, TYLENOL, ERGOCALCIFEROL, PEPCID, PLAQUENIL. Patient recovered.


Velcade Side Effects Report #5302250-9
VELCADE problem was reported by a Physician from JAPAN on Apr 04, 2007. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, platelet count decreased, pulmonary alveolar haemorrhage, . VELCADE dosage: 2.20 MG. Patient recovered.

Decadron Side Effects Report #5258207-X
Consumer or non-health professional from UNITED STATES reported DECADRON problem on Feb 27, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g increased, confusional state, hypoglycaemia, loss of consciousness, . DECADRON dosage: unknown. During the same period patient was treated with REVLIMID, THALOMID, ACYCLOVIR, FOLIC ACID, BACTRIM DS. Patient was hospitalized. Patient recovered.

Levaquin Side Effects Report #5673207-3
LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Female patient, 45 years of age, weighting 180.0 lb, was diagnosed with urinary tract infection, hypothyroidism, nutritional support, pain and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: back pain, blood immunoglobulin g increased, fatigue, muscle twitching, muscular weakness, neuropathy peripheral, sensory loss, sexual dysfunction, . LEVAQUIN dosage: unknown. During the same period patient was treated with SYNTHROID, OMEGA, VITAMIN B, VITAMIN CAP, ADVIL. Patient recovered.

Clarithromycin Side Effects Report #5526227-3
Physician from JAPAN reported CLARITHROMYCIN problem on Nov 20, 2007. Male patient, 78 years of age, was diagnosed with pharyngitis, nail tinea, neuropathy peripheral, gastritis, anal fistula, insomnia and was treated with CLARITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, blood immunoglobulin g increased, blood immunoglobulin m increased, blood lactate dehydrogenase increased, c-reactive protein increased, eosinophil count increased, hyperhidrosis, lymphocyte morphology abnormal, . CLARITHROMYCIN dosage: 400 MG/D. During the same period patient was treated with HOCHUUEKKITOU, CONFATANIN, LAMISIL, MECOBALAMIN, MARZULENE S, NERIPROCT, DEPAS. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5528290-2
PROGRAF problem was reported by a Health Professional from FRANCE on Nov 05, 2007. Female patient, 49 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, blood immunoglobulin g increased, bone marrow failure, mucosal inflammation, pancytopenia, purpura, pyrexia, thrombocytopenia, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with ROVALCYTE, PANTOPRAZOLE, DELURSAN. Patient was hospitalized. Patient recovered.


Lamisil Side Effects Report #5441332-8
Consumer or non-health professional from FRANCE reported LAMISIL problem on Aug 28, 2007. Male patient, 84 years of age, was diagnosed with tinea pedis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: back pain, blood immunoglobulin g increased, joint swelling, mobility decreased, myalgia, pain in extremity, peripheral nerve lesion, polyarthritis, rheumatoid factor increased, . LAMISIL dosage: 250 MG, QD. Patient recovered.

Lipitor Side Effects Report #5474378-4
LIPITOR problem was reported by a Physician from UNITED STATES on Sept 28, 2007. Male patient, 71 years of age, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, blood immunoglobulin g increased, coagulopathy, hepatitis acute, liver injury, tremor, . LIPITOR dosage: 10 MG QD. During the same period patient was treated with SAW PALMETTO. Patient recovered.

Darbepoetin Side Effects Report #5377509-X
Physician from SPAIN reported DARBEPOETIN ALFA problem on June 20, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with DARBEPOETIN ALFA. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood immunoglobulin g increased, cardiac disorder, respiratory disorder, urine amylase increased, . DARBEPOETIN ALFA dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, DIGOXIN, ACENOCOUMAROL, MELPHALAN, PREDNISONE, ZOLEDRONIC ACID, BORTEZOMIB, CALCIUM CHLORIDE. Patient died.

Lamisil Side Effects Report #5377518-0
LAMISIL problem was reported by a Physician from JAPAN on June 26, 2007. Female patient, 77 years of age, was diagnosed with nail tinea, hyperlipidaemia, hypertension and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aspiration bone marrow, blood immunoglobulin g increased, haemorrhage subcutaneous, idiopathic thrombocytopenic purpura, . LAMISIL dosage: 125 MG/DAY. During the same period patient was treated with LIPITOR, ADALAT. Patient recovered.

Darbepoetin Side Effects Report #5386397-7
Physician from SPAIN reported DARBEPOETIN ALFA problem on July 02, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with DARBEPOETIN ALFA. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood immunoglobulin g increased, cardiac disorder, respiratory disorder, urine amylase increased, . DARBEPOETIN ALFA dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, DIGOXIN, ACENOCOUMAROL, MELPHALAN, PREDNISONE, ZOLEDRONIC ACID, BORTEZOMIB, CALCIUM CHLORIDE. Patient died.


Myozyme Side Effects Report #5401311-3
MYOZYME problem was reported by a Physician from UNITED STATES on July 11, 2007. Female patient, 61 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii, infusion related reaction, prophylaxis and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood immunoglobulin g increased, bradycardia, chills, hypotension, hypothermia, infusion related reaction, myocardial infarction, pallor, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with EPINEPHRINE, EVISTA, CALTRATE, ALPHAGAN, CENTRUM, ADVIL. Patient was hospitalized. Patient recovered.

Darbepoetin Side Effects Report #5377509-X
Physician from SPAIN reported DARBEPOETIN ALFA problem on June 20, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with DARBEPOETIN ALFA. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood immunoglobulin g increased, cardiac disorder, respiratory disorder, urine amylase increased, . DARBEPOETIN ALFA dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, DIGOXIN, ACENOCOUMAROL, MELPHALAN, PREDNISONE, ZOLEDRONIC ACID, BORTEZOMIB, CALCIUM CHLORIDE. Patient died.

Lamisil Side Effects Report #5377518-0
LAMISIL problem was reported by a Physician from JAPAN on June 26, 2007. Female patient, 77 years of age, was diagnosed with nail tinea, hyperlipidaemia, hypertension and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aspiration bone marrow, blood immunoglobulin g increased, haemorrhage subcutaneous, idiopathic thrombocytopenic purpura, . LAMISIL dosage: 125 MG/DAY. During the same period patient was treated with LIPITOR, ADALAT. Patient recovered.

Darbepoetin Side Effects Report #5386397-7
Physician from SPAIN reported DARBEPOETIN ALFA problem on July 02, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with DARBEPOETIN ALFA. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood immunoglobulin g increased, cardiac disorder, respiratory disorder, urine amylase increased, . DARBEPOETIN ALFA dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, DIGOXIN, ACENOCOUMAROL, MELPHALAN, PREDNISONE, ZOLEDRONIC ACID, BORTEZOMIB, CALCIUM CHLORIDE. Patient died.

Myozyme Side Effects Report #5401311-3
MYOZYME problem was reported by a Physician from UNITED STATES on July 11, 2007. Female patient, 61 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii, infusion related reaction, prophylaxis and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood immunoglobulin g increased, bradycardia, chills, hypotension, hypothermia, infusion related reaction, myocardial infarction, pallor, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with EPINEPHRINE, EVISTA, CALTRATE, ALPHAGAN, CENTRUM, ADVIL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5776075-4
Physician from GERMANY reported REVLIMID problem on June 04, 2008. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood immunoglobulin g increased, protein total increased, . REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5796386-6
MYOZYME problem was reported by a Physician from UNITED STATES on June 19, 2008. Female patient, child 9 years of age, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood immunoglobulin g increased, catheter site erythema, catheter site pruritus, cough, dyspnoea, flushing, headache, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BENADRYL. Patient recovered.

Levaquin Side Effects Report #5736290-2
Physician from UNITED STATES reported LEVAQUIN problem on May 06, 2008. Female patient, weighting 199.0 lb, was diagnosed with urinary tract infection, hypothyroidism, nutritional support, pain and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: back pain, blood immunoglobulin g increased, burning sensation, fatigue, muscle twitching, muscular weakness, neuropathy peripheral, pelvic pain, . LEVAQUIN dosage: unknown. During the same period patient was treated with SYNTHROID, OMEGA, VITAMIN B, VITAMIN CAP, ADVIL. Patient recovered.

Myozyme Side Effects Report #5692632-8
MYOZYME problem was reported by a Physician from UNITED STATES on Mar 19, 2008. Male patient, 22 years of age, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: arthropathy, blood immunoglobulin g increased, hypochromic anaemia, joint effusion, oedema peripheral, pain in extremity, pain in jaw, pleuritic pain, red blood cell sedimentation rate increased, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5716859-1
Physician from FRANCE reported FABRAZYME problem on Apr 08, 2008. Male patient, 45 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood immunoglobulin g increased, hypertension, hypoglycaemia, shock, tachycardia, . FABRAZYME dosage: 54 MG, INTRAVENOUS. Patient recovered.

Fabrazyme Side Effects Report #5306748-9
FABRAZYME problem was reported by a Physician from MEXICO on Apr 10, 2007. Male patient, 44 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood immunoglobulin g increased, chills, cough, dry mouth, dyspnoea, hyperhidrosis, infusion related reaction, tachycardia, . FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, CARBAMAZEPINE, GABAPENTIN. Patient recovered.

Lamisil Side Effects Report #5276819-4
Physician from JAPAN reported LAMISIL problem on Mar 15, 2007. Female patient, 77 years of age, was diagnosed with nail tinea, hyperlipidaemia, hypertension and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aspiration bone marrow, blood immunoglobulin g increased, haemorrhage subcutaneous, idiopathic thrombocytopenic purpura, . LAMISIL dosage: 125 MG/DAY. During the same period patient was treated with LIPITOR, ADALAT. Patient recovered.

Myozyme Side Effects Report #5614459-5
MYOZYME problem was reported by a Physician from UNITED STATES on Jan 21, 2008. Female patient, 37 years of age, weighting 112.2 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood immunoglobulin e increased, blood immunoglobulin g increased, chest discomfort, chest pain, dyspnoea, infusion related reaction, oedema peripheral, rash, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, BENADRYL, TOPROL, CELEBREX, PAXIL. Patient recovered.

Furadantin Side Effects Report #5552121-8
Physician from FRANCE reported FURADANTIN problem on Nov 26, 2007. Female patient, 81 years of age, was treated with FURADANTIN. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin a increased, blood immunoglobulin e increased, blood immunoglobulin g increased, blood immunoglobulin m increased, leukocytoclastic vasculitis, . FURADANTIN dosage: unknown. During the same period patient was treated with INEXIUM, TOPAAL, BACTRIM, LERCANIDIPINE. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5512664-X
MYOZYME problem was reported by a Physician from CHINA on Oct 22, 2007. Female patient, child 2 years of age, weighting 13.87 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, alpha haemolytic streptococcal infection, blood immunoglobulin g increased, blood sodium decreased, cardiac failure, condition aggravated, electrolyte imbalance, fluid retention, gene mutation identification test positive, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with MILRINONE. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5524753-4
Physician from GERMANY reported EXJADE problem on Nov 19, 2007. Female patient, 17 years of age, was diagnosed with haemosiderosis and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: antibody test positive, blood immunoglobulin a increased, blood immunoglobulin g increased, campylobacter infection, diplopia, guillain-barre syndrome, ivth nerve paresis, monoparesis, quadriplegia, . EXJADE dosage: 1750 MG, QD. During the same period patient was treated with ROCALTROL, CYCLO. Patient was hospitalized. Patient recovered.

Strattera Side Effects Report #5499298-0
STRATTERA problem was reported by a Physician from UNITED STATES on Oct 01, 2007. Female patient, child 11 years of age, weighting 70.11 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: arthralgia, autoimmune hepatitis, blood immunoglobulin g increased, coagulopathy, condition aggravated, hepatic fibrosis, liver injury, liver palpable subcostal, pyrexia, . STRATTERA dosage: unknown. Patient recovered.

Strattera Side Effects Report #5502078-0
Physician from UNITED STATES reported STRATTERA problem on Oct 22, 2007. Female patient, child 11 years of age, weighting 70.11 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: arthralgia, autoimmune hepatitis, blood immunoglobulin g increased, diarrhoea, fatigue, liver palpable subcostal, prothrombin time prolonged, pyrexia, spleen palpable, . STRATTERA dosage: 30 MG, DAILY (1/D). Patient recovered.

Zetia Side Effects Report #5403338-4
ZETIA problem was reported by a Health Professional from UNITED KINGDOM on July 26, 2007. Female patient, 70 years of age, weighting 132.3 lb, was diagnosed with type iia hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, autoimmune hepatitis, blood immunoglobulin g increased, liver function test abnormal, . ZETIA dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, AZITHROMYCIN. Patient was hospitalized and became disabled. Patient recovered.

Menotrophin Side Effects Report #5798827-7
Physician from SERBIA reported MENOTROPHIN problem on Feb 25, 2008. Female patient, 28 years of age, was diagnosed with anovulatory cycle and was treated with MENOTROPHIN. After drug was administered, patient experienced the following problems/side effects: antiphospholipid syndrome, beta-2 glycoprotein antibody positive, blood immunoglobulin g increased, blood immunoglobulin m increased, cardiac myxoma, complement factor c3 increased, complement factor c4 increased, complication of pregnancy, hirsutism, . MENOTROPHIN dosage: unknown. During the same period patient was treated with CHORIOANIC GONADOTROPIN, CLOMIPHENE ACETATE, ESTROGEN. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5363268-3
TERBINAFINE problem was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, 57 years of age, was treated with TERBINAFINE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood immunoglobulin a increased, blood immunoglobulin g increased, chronic hepatitis, contusion, hepatic cirrhosis, hepatic necrosis, hepatitis b, hepatomegaly, . TERBINAFINE dosage: unknown. Patient recovered.

Aranesp Side Effects Report #5323557-5
Physician from GERMANY reported ARANESP problem on May 04, 2007. Female patient, weighting 79.37 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-erythropoietin antibody positive, blood immunoglobulin g increased, c-reactive protein increased, catheter related infection, haematoma, immunoglobulins increased, inflammation, . ARANESP dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, ENALAPRIL, CALCIUM ACETATE, NEXIUM, METOCLOPRAMIDE, AZITHROMYCIN, AMLODIPINE, NOVAMINSULFON. Patient recovered.

Temodal Side Effects Report #5291128-5
TEMODAL problem was reported by a Physician from FRANCE on Mar 22, 2007. Female patient, 60 years of age, weighting 172.0 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: anaemia, anal ulcer, blood immunoglobulin g increased, cheilitis, citrobacter infection, dysphagia, herpes virus infection, hypogammaglobulinaemia, leukopenia, . TEMODAL dosage: unknown. During the same period patient was treated with LASIX, BACTRIM. Patient was hospitalized. Patient recovered.

Rosiglitazone Side Effects Report #5310036-4
Health Professional from NETHERLANDS reported ROSIGLITAZONE MALEATE problem on Apr 20, 2007. Female patient, 77 years of age, weighting 152.1 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with ROSIGLITAZONE MALEATE. After drug was administered, patient experienced the following problems/side effects: anaemia, aortic valve stenosis, blood immunoglobulin g increased, blood immunoglobulin m increased, breast oedema, cardiac murmur, constipation, dizziness, . ROSIGLITAZONE MALEATE dosage: 4MG TWICE PER DAY. During the same period patient was treated with OMEPRAZOLE, LETROZOLE, FUROSEMIDE, METFORMIN, PASSIFLORA, VENOPLANT. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about BLOOD IMMUNOGLOBULIN G INCREASED side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about BLOOD IMMUNOGLOBULIN G INCREASED